Outset Medical (OM) Share-based Compensation (2019 - 2026)
Outset Medical's (OM) quarterly Share-based Compensation came in at $2.7 million in Q2 2026, down 22.88% year-over-year from $3.5 million in Q2 2025, and down 21.92% quarter-over-quarter from $3.5 million in Q1 2026.
Analysis
Outset Medical (OM) Share-based Compensation (2019 - 2026) Analysis & Trends
Outset Medical (OM) has reported Share-based Compensation for 8 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Share-based Compensation fell 22.88% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $15.3 million, a 14.12% decrease from a year earlier, with the FY2025 full-year figure at $15.6 million, down 46.8% from the prior year.
- Share-based Compensation was $2.7 million for Q2 2026 at Outset Medical, down from $3.5 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $10.9 million in Q3 2023 and troughed at $2.7 million in Q2 2026.
- A 5-year average of $6.5 million and a median of $6.9 million in 2022 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 159.43% in 2022 and sank 64.4% in 2025, its largest moves.
- Over 5 years, Share-based Compensation stood at $7.4 million in 2022, then climbed by 23.73% to $9.1 million in 2023, then plunged by 45.65% to $4.9 million in 2024, then slipped by 17.84% to $4.1 million in 2025, then slumped by 33.65% to $2.7 million in 2026.
- The last three Share-based Compensation figures came in at $2.7 million (Q2 2026), $3.5 million (Q1 2026), and $4.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.85 Bn | 174.25 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Intuitive Surgical | 127.70 Bn | 122.49 Bn | 1.96 Bn | 67.10 Mn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 125.00 Mn |
| 4 | Stryker | 103.83 Bn | 100.35 Bn | 4.50 Bn | 7.00 Mn |
| 5 | Boston Scientific | 63.05 Bn | 62.51 Bn | 3.85 Bn | 61.00 Mn |
| 6 | Edwards Lifesciences | 49.81 Bn | 45.55 Bn | 1.35 Bn | 42.20 Mn |
| 7 | Alcon | 32.94 Bn | 31.48 Bn | 1.68 Bn | 42.00 Mn |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | 39.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Outset Medical | 59.95 Mn | -203.24 Mn | 13.28 Mn | 2.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.70 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 4.06 Mn |
| Sep 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 3.50 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 9.82 Mn |
| Mar 31, 2024 | 8.20 Mn |
| Dec 31, 2023 | 9.10 Mn |
| Sep 30, 2023 | 10.89 Mn |
| Jun 30, 2023 | 10.11 Mn |
| Mar 31, 2023 | 8.54 Mn |
| Dec 31, 2022 | 7.35 Mn |
| Sep 30, 2022 | 7.43 Mn |
| Jun 30, 2022 | 7.41 Mn |
| Mar 31, 2022 | 5.01 Mn |
| Dec 31, 2021 | 4.79 Mn |
| Sep 30, 2021 | 2.86 Mn |